Image

A Phase 1 Multi-center Open-label Dose De-escalation Study to Evaluate the Safety and Efficacy of Talimogene Laherparepvec in Pediatric Subjects with Advanced Non-Central Nervous System Tumors That are Amenable to Direct Injection

Investigating the Safety of Intralesional Investigational Medication in Children with Advanced Growths

Recruiting
2-21 years
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the safety of an investigational medication given directly into tumors in children with advanced solid tumors outside the brain. These tumors must be ones that can be directly injected. The purpose is to understand how the body responds to this treatment and to ensure it is safe for children.

Participants will receive the investigational medication through injections directly into their tumors. This study will help researchers learn more about how the medication works in the body and if there are any side effects. The medication is given in a clinical setting where doctors can monitor the participants closely.

  • Who can participate: Children with advanced solid tumors outside the brain and spinal cord that have returned after standard treatment or have no other standard treatment available can participate. They must have a life expectancy of more than 4 months and be able to receive injections directly into their growths.
  • Study details: Participants will receive injections of the investigational medication directly into their growths. The study will monitor their response to the treatment and any side effects experienced.
Print
Study details
    Advanced Non-Central Nervous System Tumor

TX6202

19 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.